TAI •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/08/2026 13:30
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeTAI
Market Capitalization52,036 mln
Float144 mln
EPS
18.05
Robust
P / E
10.94
Fair value
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.46
Borderline
1-Year Forecast
367
Transformational upside
Relative Strength
40
/ 100
Slightly lagging
Business Description
Founded in 1966 and based in Taipei, Taiwan, Lotus Pharmaceutical develops, manufactures, and sells generic medicines across Taiwan, South Korea, the United States, and other markets worldwide. The company specializes in treatments for cancer, neurological conditions, heart disease, women's health, and weight management. Beyond making and selling medicines, Lotus also supports healthcare clients through consulting, regulatory guidance, research services, and health management advisory work.
